We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Apply for an import certificate to import a medicinal product into the UK for veterinary use.
The actions to take for sourcing medicines in different circumstances.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
The CMU is part of the Medicine, Pharmacy and Industry Group of DHSC which looks at supply and procurement in hospitals.
Information about how to register your homeopathic medicinal product through the Simplified Homeopathic Registration Scheme or the UK Homeopathic National Rules Scheme
Guidance on naming human medicines, including Braille requirements for the name on the product label.
You must get permission to export certain drugs and medicines.
Actions that trial sponsors should consider to build resilience into clinical trial design
Ways to link technology, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines
Links to EU guidance, as it stood immediately before end of transition period.
How to carry out a clinical trial to apply for a marketing authorisation, manage your authorisation and report safety issues.
Guidance on medicines for food and non-food horses and record keeping requirements including the horse passport.
The medicines regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the continued need for COVID-19 medicines that are safe, effective and of high quality
Guidance following recommendations from the Commission on Human Medicines.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
E-learning modules for healthcare professionals on minimising the risks of using medicines and information on how to access medical device modules.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).